yttrium-90

Known as: Yttrium Y-90, yttrium Y 90, 90Y 
A radioactive form of the rare metal yttrium that is used in radiation therapy to treat some types of tumors. Yttrium Y 90 can be linked to a… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
UNLABELLED A multicenter analysis was conducted to evaluate the main prognostic factors driving survival after radioembolization… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND & AIMS Hepatocellular carcinoma (HCC) has limited treatment options; long-term outcomes following intra-arterial… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2010
Highly Cited
2010
UNLABELLED Radioembolization has been demonstrated to allow locoregional therapy of patients with hepatocellular carcinoma not… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Radioembolization with yttrium-90 microspheres (90Y-RE), either glass- or resin-based, is increasingly applied in patients with… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE To standardize the indications, techniques, multimodality treatment approaches, and dosimetry to be used for yttrium-90… (More)
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Hepatic arterial therapy with yttrium-90 microspheres exploits the avenue provided by the neoplastic microvasculature to deliver… (More)
Is this relevant?
Review
2005
Review
2005
Management of hepatic malignancies is a ubiquitous medical problem. Surgical resection of primary or metastatic liver cancer… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE Radioimmunotherapy combines biologic and radiolytic mechanisms to target and destroy tumor cells, thus offering a needed… (More)
Is this relevant?
Review
2002
Review
2002
Hepatocellular carcinoma (HCC) constitutes a difficult health challenge because of its poor prognosis and limited treatment… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
In a pilot study, DOTA-d-Phe1-Tyr3-octreotide (DOTATOC), which can be labelled with the β-emitting radioisotope yttrium-90, has… (More)
  • table 2
  • figure 2
  • figure 1
  • figure 4
  • figure 3
Is this relevant?